Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Janet Middle
Observed name:
Middle, Janet
Institutions:
Sheffield Teaching Hospitals NHS Foundation Trust,
NIHR Sheffield Biomedical Research Centre,
University of Sheffield
Observed institutions:
University of Dundee,
Sheffield Teaching Hospitals NHS Foundation Trust,
NIHR Sheffield Biomedical Research Centre,
Medical Research Council,
University of Sheffield
OpenAlex ID:
A5028507845
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Eugenia Abaleke
, Mustafa Abbas
, et al.
·
The Lancet
·
589
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
569
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
2022
·
Paul R Kalra
, John G F Cleland
, et al.
·
The Lancet
·
486
PDF
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
425
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
383
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
2019
·
Derek J Hausenloy
, Rajesh K Kharbanda
, et al.
·
The Lancet
·
372
PDF
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
315
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
2017
·
Guy E Thwaites
, Matthew Scarborough
, et al.
·
The Lancet
·
217
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
156
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
2019
·
Michael Mullen
, Xu Yu Jin
, et al.
·
The Lancet
·
142
PDF
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial
2024
·
John G F Cleland
, Philip A Kalra
, et al.
·
European Heart Journal
·
52
PDF
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction
2023
·
Robin Ray
, Ian Ford
, et al.
·
Journal of Cardiac Failure
·
6
Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrel
2025
·
Mark A. Sammut
, Mohammed E. F. Rahman
, et al.
·
Platelets
·
3
Oral Presentation No. 84 Initial clinical experience with 6-hour enoxaparin regimen in opiate-treated patients undergoing primary percutaneous coronary intervention
2022
·
Nadir Elamin
, Kok Weng Ow
, et al.
·
Cardiovascular Research
PDF
Thromboinflammatory Response to On-pump Coronary Artery Bypass Graft Surgery Leads to Impaired Platelet Reactivity in Patients With Acute Coronary Syndrome
2022
·
Nadir Elamin
, Thomas Nelson
, et al.
·
Journal of the American College of Cardiology
Show more works
View as search
Works count:
16
Citation count:
3,715
H-index:
11
I10-index:
11
Year
Topic
Type